Jennifer Bramen, PhD is a neuroscientist with expertise in neuroscience research, advanced neuroimaging, and non-pharmacological interventions for cognitive decline. She obtained her PhD in Neuroscience from the University of California, Los Angeles (UCLA), where she also completed her postdoctoral research fellowship at the Laboratory of Neuroimaging (LONI). During her time as an Assistant Research Neuroscientist at the UCLA’s Center for Cognitive Neuroimaging, she made significant contributions to the field. She published groundbreaking work on real-time fMRI technology aimed at in-scanner neurofeedback to reduce craving levels in smokers. As part of her work with the UCLA Center on Aging, she conducted research focused on the early diagnosis of Alzheimer's disease using techniques such as FDG PET and hippocampal unfolding. She was also a lecturer in the Neuroimaging Training Program.Dr. Bramen currently serves as a Senior Research Scientist at the Pacific Neuroscience Institute Foundation (PNIF), an emerging neuroscience research organization housed within the Pacific Brain Health Center (PBHC), an outpatient dementia care clinic and center of excellence in the Providence St. Joseph Health system. At PBHC, she leads the Neuroimaging Core, which provides neuroimaging-based biomarkers and supports automated data abstraction from the electronic health record to facilitate a better understanding clinical outcomes and measure the efficacy of clinical trials. Dr. Bramen's research primarily focuses on interventions for Alzheimer's disease (AD) and related dementias. She has made notable contributions to the field as the inventor of AD-NeuroScore, a novel sMRI-based metric that utilizes clinically available measures and a novel (patent pending) algorithm to assess neurodegeneration associated with AD. AD-NeuroScore is distinguished by its clinical feasibility, interpretability, and its potential to improve the patient experience. It accounts for variations in scans performed at different facilities with different scanners, ensuring the validity of longitudinal follow-up reports. Furthermore, Dr. Bramen is engaged in intervention research aimed at improving multi-modal lifestyle interventions. She employs a combination of coaching and precision-medicine to improve behavior change. She also collaborates with the Institute for Systems Biology (ISB) on systems biology research to improve personalized medicine by understanding the complex interactions between environment, genetics, and physiological systems measured using metabolomics and proteomics.